Drug Information

Drug General Information
Drug ID
D0GS1B
Former ID
DNC013681
Drug Name
1-(2-morpholinoethyl)-1H-indol-3-yl acetate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528907]
Formula
C16H20N2O3
Canonical SMILES
CC(=O)OC1=CN(C2=CC=CC=C21)CCN3CCOCC3
InChI
1S/C16H20N2O3/c1-13(19)21-16-12-18(15-5-3-2-4-14(15)16)7-6-17-8-10-20-11-9-17/h2-5,12H,6-11H2,1H3
InChIKey
WNJZFVIJUKGTLU-UHFFFAOYSA-N
PubChem Compound ID
24851127
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [528907]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 528907Eur J Med Chem. 2008 Mar;43(3):513-39. Epub 2007 May 6.Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.
Ref 528907Eur J Med Chem. 2008 Mar;43(3):513-39. Epub 2007 May 6.Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.